پیکامیلون
Sign in to savePicamilon (also known as '''N-nicotinoyl-GABA, pycamilon, and pikamilon''') is a drug formed by a synthetic combination of niacin and γ-aminobutyric acid (GABA). It was developed in the Soviet Union in 1969 and further studied in both Russia and Japan as a prodrug of GABA.
Research
56 papers- Picamilon, a γ-aminobutyric acid (GABA) analogue and marketed nootropic, is inactive against 50 biological targets.Basic & clinical pharmacology & toxicology · 2023
- [Clinical efficacy and safety of Picamilon in patients with progressive chronic cerebral ischemia].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2024
- [Integrative assessment of the effectiveness and safety of outpatient use of Picamilon].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2024
- Determination of picamilon concentration in human plasma by liquid chromatography-tandem mass spectrometry.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2010
- [Treatment of patients with chronic cerebral ischemia: experience of using the combined neuroprotective drug Picamilon Ginkgo].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2022
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 208.085
Show 5 more facts
- canonical SMILES
- C1=CC(=CN=C1)C(=O)NCCCC(=O)O
- chemical formula
- C₁₀H₁₂N₂O₃
- subject has role
- nootropic
- Commons category
- Picamilon
- native label
- Picamilonum
via Wikidata · CC0